Roche Diagnostics Co., Ltd. Roche Diagnostics Co., Ltd. (Headquarters: Minato-ku, Tokyo / President and CEO: Nobu Ogasawara) commemorates the 125th anniversary of the Roche Group and the 50th anniversary of the testing drug business in Japan. We reported on the online talk event "Life Talks Japan". Roche Diagnostics, as a Japanese subsidiary of the Roche Group's diagnostics business, founded in Switzerland, has contributed to improving people's health by providing testing solutions. Under the pandemic caused by the new coronavirus infection (COVID-19), we launched the first PCR test drug in Japan, and after that, we launched a series of reagents for antibody test, antigen test, and virus mutation to meet various test needs. I am responding. Roche is also a world leader in pathological testing solutions that are essential for cancer diagnosis and has contributed to the development of state-of-the-art personalized medicine that treats with personalized medicine. .. The introduction of a diagnostic support system that enables the aggregation and retrieval of data necessary for cancer gene therapy to domestic facilities has also begun. The first talk event to commemorate the anniversary is entitled "The Age of Coexistence with Post COVID-19 Testing", and while it is said that it is extremely difficult to completely eradicate the virus, how should human beings coexist with infectious diseases from now on? Together with statisticians, creators, and journalists, I thought about actions for the future based on data. The second talk event, entitled "Innovation called'Cancer Personalized Medicine'", is to promote and establish personalized medicine, which has high expectations in Japan, where one in two people will have cancer. We invited doctors and entrepreneurs to discuss the role and potential of digital solutions such as. Details of the event report are posted on our website. https://www.roche-diagnostics.jp/ja/about/roche_125/lifetalks_japan_archive/report.html The two talk events do not require registration and can be viewed for free until 21:00 on December 26, 2021. Talk 1: Post COVID-19 Era of coexistence with inspection Viewing URL: https://v2.nex-pro.com/campaign/MzQ4NjA%253D Talk 2: Innovation viewing URL of "personalized medicine for cancer": https: / /v2.nex-pro.com/campaign/MzQ4NjI%253D Company Profile Celebrating the 125th anniversary of its founding, the Roche Group is one of the world's leading biotech companies that continues to innovate in the healthcare industry. We have both medicines and diagnostics to help healthcare professionals and patients make optimal treatment choices and decisions at all stages of health, prevention, diagnosis, treatment and prognosis. Roche Diagnostics Co., Ltd. is a Japanese subsidiary of the Roche Diagnostic Drugs Business Unit. The diagnostic drug business in Japan has 50 years of experience and achievements. As of January 2021, it has 728 employees and offices in 8 cities nationwide. In-vitro diagnostic drug / medical device business, research reagent / device business. We are developing in a wide range of fields. We aim to shape the future of healthcare through diagnostic innovation and help people lead a healthier and more personal life. For more information, please visit http://www.roche-diagnostics.jp. Roche 125th Anniversary, 50th Anniversary of Diagnostic Drug Business in Japan Special Page: www.roche-diagnostics.jp/ja/about/roche_125.html In commemoration of the anniversary, the history of diagnostic drug business in Japan and medical examinations We publish content that conveys the importance. * The following is special information limited to media personnel. Please refrain from disclosing information on personal SNS etc.
This press release contains information for the media.
If you register as a media user, you can view various special information such as contact information of the person in charge of the company and information on events and press conferences. * Contents vary depending on the press release.
- Press Release>
- Roche Diagnostics Co., Ltd.>
- A report on his talk event, which considers "post-corona society" and "personalized cancer medicine" by utilizing AI and data, is being distributed free of charge without registration.
- Business category
- Pharmaceuticals / Pharmaceuticals / Hospitals